New Leaf Venture Partners’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-117,242
Closed -$348K 19
2022
Q3
$348K Hold
117,242
0.21% 16
2022
Q2
$428K Hold
117,242
0.28% 17
2022
Q1
$726K Hold
117,242
0.36% 17
2021
Q4
$950K Hold
117,242
0.34% 19
2021
Q3
$1.75M Hold
117,242
0.5% 20
2021
Q2
$7.97M Hold
117,242
2.05% 8
2021
Q1
$533K Hold
117,242
0.12% 18
2020
Q4
$251K Hold
117,242
0.06% 17
2020
Q3
$273K Hold
117,242
0.11% 18
2020
Q2
$236K Hold
117,242
0.07% 20
2020
Q1
$85K Hold
117,242
0.03% 20
2019
Q4
$311K Hold
117,242
0.07% 19
2019
Q3
$396K Hold
117,242
0.12% 19
2019
Q2
$702K Buy
+117,242
New +$767K 0.19% 20
2019
Q1
Sell
-117,243
Closed -$753K 22
2018
Q4
$753K Hold
117,243
0.21% 19
2018
Q3
$1.92M Hold
117,243
0.35% 18
2018
Q2
$2.42M Hold
117,243
0.58% 14
2018
Q1
$2.77M Hold
117,243
1.49% 12
2017
Q4
$22M Hold
117,243
10.28% 2
2017
Q3
$25.2M Hold
117,243
11.68% 3
2017
Q2
$24.1M Hold
117,243
16.9% 3
2017
Q1
$21.4M Hold
117,243
10.94% 3
2016
Q4
$29.3M Hold
117,243
20.99% 2
2016
Q3
$24.4M Hold
117,243
17.57% 3
2016
Q2
$23.7M Hold
117,243
20.4% 1
2016
Q1
$21.5M Hold
117,243
19.42% 1
2015
Q4
$29.3M Buy
+117,243
New +$37.8M 19.62% 1

Other funds holding PDSB

New Leaf Venture Partners's PDSB Position: Q4 2022 in Review

New Leaf Venture Partners sold out of PDS Biotechnology (PDSB) in Q4 2022, closing a stake of 117,242 shares — an estimated $348K sold.

New Leaf Venture Partners first reported a position in PDSB in Q4 2015 and held it in 27 quarters. The position peaked at $29.3M in Q4 2016. 64 funds tracked by Wall St. Rank hold PDSB as of Q4 2022.

  • New Leaf Venture Partners reported no remaining PDS Biotechnology position as of Q4 2022 after selling out during the quarter.
  • New Leaf Venture Partners sold 117,242 PDS Biotechnology shares in Q4 2022, an estimated $348K.
  • New Leaf Venture Partners first reported a position in PDS Biotechnology in Q4 2015 and held it in 27 quarters.
  • New Leaf Venture Partners's PDS Biotechnology position peaked at $29.3M in Q4 2016.
  • 64 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2022.

Based on New Leaf Venture Partners's 13F filing for Q4 2022, filed 6 Feb 2023.